Miraluma breast imaging for breast cancer
Dense, fibrous breast tissue makes the accurate identification of tumors and abnormal structures difficult. The Miraluma test can produce striking pictures of malignant lesions, even in the midst of dense and fibrous breast tissue. This helps us detect and identify malignancies in the breasts that other tests may have missed, and early on.
Also, the test often reduces the number of breast biopsies needed, and does not involve compressing the breasts as in a mammogram.
What is miraluma breast imaging?
Miraluma breast imaging is a non-invasive nuclear medicine test that produces striking pictures of malignant lesions in the midst of dense, fibrous breast tissue.
During this test, the patient receives a small amount of a radioactive substance by injection. Then, a Gamma camera takes detailed images of the breasts. The radiopharmaceutical tends to accumulate differently in cancerous and non-cancerous tissues.